Stryker subsidiary Howmedica Osteonics, an orthopedics manufacturer, settled a trade secret disagreement with Zimmer Biomet, according to Life Sciences Intellectual Property Review.
Four U.S. surgeons performed the first spine surgeries with Emerging Implant Technologies' implants.
The Internal Revenue Services is arguing in federal court to increase Medtronic's taxable income by around $1.4 billion related to its factories in Puerto Rico, according to the Star Tribune. 
The global spinal cord stimulators market is set to grow at a 6.4 percent compound annual growth rate through 2027, according to a Future Market Insights report.
The cervical total disc replacement device market is anticipated to reach $1.75 billion by 2021, growing at a 23.1 percent compound annual growth rate.
Medtronic unveiled new telehealth solutions.
Medicrea acquired three new patents related to interbody devices.
Market analysts predict the U.S. orthopedic trauma devices market will see a 3.63 percent compound annual growth rate through 2021.
With a rising geriatric population and developing minimally invasive surgery sector, orthopedic implant manufacturers continue to make strides to stay competitive. Dean Carson, PhD, the vice president of U.S. operations at Anatomics, a privately owned and neurosurgeon-founded company, discuses the challenges, developments and future of the orthopedic implant industry.
With FDA approval of its Excelsius GPS in place, Globus Medical set itself up to stand as Mazor Robotics biggest rival in the spine market, according to The Motley Fool.
OrthoPediatrics Corp. will serve as a platinum sponsor of the 14th Annual International Pediatric Orthopaedic Symposium in Orlando, Fla., from Nov. 28 through Dec. 2.
Here are seven recently launched or released devices.
Medicrea received FDA clearance for its IB3D range of 3-D printed titanium interbody devices and introduced AdapTEK.
Medtronic reported a 4 percent dip in revenue due to hurricanes during the second quarter of the 2017 fiscal year, as well as a divestiture to Cardinal Health.
Market analysts predict the global bioactive fillings market will experience a 9.2 percent compound annual growth rate between 2017 and 2023.
Medtronic reported second quarter worldwide revenue dropped 4 percent due to the company's divestiture of the Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses to Cardinal Health.
The global interventional spine devices market is predicted to grow at a steady compound annual growth rate of 10.5 percent until 2021, according to MILTECH.
Although reporting $19.7 billion total sales in the third quarter of 2017, Johnson & Johnson's spine division saw a decline in sales, according to Market Realist.
Highmark issued a new medical policy, "Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)."
The FDA cleared 19 spine-related medical devices in October.
Page 3 of 50

Top 40 Articles from the Past 6 Months